Chiron has appointed Dr Jack Goldstein as president and chief operating officer. Dr Goldstein has served in this capacity on an interim basis since November 2004.
Mover of the month: Jack Goldstein
Chiron has appointed Dr Jack Goldstein as president and chief operating officer. Dr Goldstein has served in this capacity on an interim basis since November 2004 and previously served as president of Chiron Blood Testing. In his new role as president and COO, he will continue to oversee Chiron's day-to-day business operations and report to CEO Howard Pien.
Altana Pharma has appointed Sylvia Nwafornso as pharmacovigilance scientist. She joins having previously worked with GSK as a drug safety scientist.
Ratiopharm International has appointed Gerard Cole as managing director of Ratiopharm UK. He brings with him over 25 years' pharmaceutical industry experience gained both in the UK and internationally with a number of large and medium sized organisations.
Cambridge Antibody Technology (CAT) has made two promotions to the key management position of vice president (VP). Lynn Lester is promoted to the position of VP, human resources. Lynn joined CAT in May 2000.
Dr Paul Varley is promoted to the position of VP, bio-pharmaceutical development, responsible for managing CAT's development activities in the areas of process, analytical and pharmaceutical sciences. Dr Varley joined the company in April 1998 as head of pharmaceutical sciences.
Pharmaceutical Profiles has appointed a new head of project management. Julie Hutchison will be responsible for ensuring there is the optimal balance and delivery of work across all of the company's divisional and project managers. Julie brings a wealth of experience to her new role, including an MSc in Clinical Science and team-leader level experience in project planning and project management at several major pharmaceutical and biotech companies.
Inpharmatica has appointed John Lisle as chief executive officer. He has over 15 years' experience in the pharma and life sciences industry. Most recently he was chief executive officer of Profile Therapeutics and previously held a variety of commercial roles at GSK and AstraZeneca.
MNLpharma has added two key personnel to its team: Dr Mike Rance as non-executive director on the board, and David Gee as commercial director. Most recently Dr Rance led the Zeneca Pharmaceuticals business development function and was part of the team responsible for the successful creation of AstraZeneca, where he is currently vice president of corporate affairs. David has more than 20 years' experience within several international healthcare companies serving in sales, marketing, strategic planning and business development roles.
Sanofi-aventis has made several new additions to the corporate communications department; Michel Joly has been appointed as VP communications and VP brand and scientific communications, while Robert Sebbag becomes VP solidarity mission on access to medicine. In the UK, Cressida Ward has been confirmed as communications director, Dr Anna Sorman as head of brand policy and public affairs, and Jeni Wilson as head of brand communications.
SantÈ Communications has announced the promotion of Jennifer Mitchell to account executive. Jennifer has been with the company for 18 months working across a diverse range of accounts.
Two senior appointments have been announced at the BMJ Publishing Group; Dr Fiona Godlee has been appointed editor of the BMJ (British Medical Journal). Dr Godlee becomes the first female editor since the journal was established in 1840. She replaces Dr Richard Smith who left the journal in July 2004. Stella Dutton has also been appointed as chief executive of the BMJ Publishing Group.
The Chartered Institute of Marketing (CIM) has appointed Lord Heseltine, chairman of Haymarket Group, as its president. Lord Heseltine is an advocate of marketing and brings extensive experience in business leadership in both the private and public sector. It is expected that Lord Heseltine will take an active role as CIM looks to put marketing squarely on the boardroom agenda.
The MSI Consultancy has appointed Nigel Thompson as head of insight. Nigel has 30 years' experience in marketing research, strategic development and marketing planning. Most recently he was managing director of specialist healthcare marketing research firm Aliquot Research.
Re-structuring within MJL Advertising has resulted in Justin McCarthy, previously client services director, taking over as managing director from Phil Ledger, who has now become chairman. Phil takes over from John Heaps who stays within the company as financial director.
Nobull Communications has appointed Lisa Penney as associate director. She has over 11 years' healthcare PR experience with particular expertise in promoting brand leading OTC medicines.
Hill & Knowlton has appointed Dr Nicola Ilett as managing director of the healthcare and pharmaceutical team. Dr Ilett began her career at Hill & Knowlton in the early 1980s. She co-founded and was joint MD of Bullet Communications. She continued to be involved in the strategic development of Blackwell's healthcare communications and publishing businesses before becoming a non-executive director of Blackwell Publishing in 2000.
PAN advertising has promoted Craig Mills to the position of director of brand planning. Craig joined over four years ago and has been involved in major campaigns for key clients, including Boehringer Ingelheim, Pfizer, MSD, Aventis and Servier.
ICM Research announces the expansion of their healthcare division, ICM Healthcare, with the appointment of new members: Heather Pollitt joins as director of the healthcare department, from NOP World Health (formerly Strategic Marketing Europe). Emma Rummings joins as research manager from NOP World Health and Taylor Nelson Sofres (TNS). Ben Gibbons will expand his role as senior project manager. He has over five years' international experience in pharmaceutical market research.
Elena Kolobkova joins Lane Earl & Cox (LEC) as account executive. She was previously marketing manager for a wine importing company in Moscow and healthcare agency DDB in Russia.
Woolley Pau has appointed a new creative team with Sam Holbrook as art director and Yvette Cumbers as copywriter. Both join from Grey Healthcare. Also joining Woolley Pau are Helen Dell as account director, Kate Ashton as account manager and Jane Applin as senior account executive.
VB Communications has announced two new promotions: Liz Maclaren has been promoted to joint creative director, while Andrea Grimes-Crompton moves up to account director.
Pope Woodhead PR has appointed two new account managers: Jacquie Bunn and Claire Elbrow. Jacquie joins from Hayward Medical Communications where she had responsibility for key accounts within the pharma industry. Claire brings more than seven years' experience, mainly within the biotechnology industry, including marketing communications, corporate PR and business development.
Steeve Lamontagne has been appointed by the Medicus Group as managing director of Discovery London. He brings with him 14 years' experience in the pharmaceutical and biotechnology industries including five years' medical education in Canada and the UK. Becky Cawthorn-Smith joins as managing director of Medicus London and has 11 years' experience working within pharmaceutical marketing agencies across the spectrum of communications.
Nolan Willis has been appointed as creative director, Medicus and Discovery London. Since graduating from The London Institute with a BA Hons in Media and Production design 12 years ago, he has been working within various integrated advertising agencies in the roles of designer, art director and creative director. Sophie Goswell has been promoted to group account director, Medicus London. She has seven years' pharma marketing experience in both the pharmaceutical and drug discovery sector, preceded by five years' in marketing and events.